TREA

90459479 - ADAPTIVE BIOTECHNOLOGIES

Follow

Information

  • Trademark
  • 90459479
  • Serial Number
    90459479
  • Registration Number
    6919052
  • Filing Date
    January 11, 2021
    4 years ago
  • Registration Date
    December 06, 2022
    2 years ago
  • Transaction Date
    December 06, 2022
    2 years ago
  • Status Date
    December 06, 2022
    2 years ago
  • Published for Opposition Date
    September 07, 2021
    3 years ago
  • Location Date
    October 28, 2022
    2 years ago
  • First Use Anywhere Date
    January 01, 2021
    4 years ago
  • First Use In Commerce Date
    January 01, 2021
    4 years ago
Information
Mark Drawing Code
5000
Mark Identification
ADAPTIVE BIOTECHNOLOGIES
Case File Statements
  • DM0000: The mark consists of the word "Adaptive" with the letter "A" being capitalized and the word "biotechnologies" in lowercase lettering.
  • GS0441: Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
  • D10000: "BIOTECHNOLOGIES"
  • GS0421: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Case File Event Statements
  • 12/6/2022 - 2 years ago
    31 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/6/2022 - 2 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/29/2022 - 2 years ago
    29 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/28/2022 - 2 years ago
    28 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/27/2022 - 2 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/26/2022 - 2 years ago
    26 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 10/17/2022 - 2 years ago
    25 - USE AMENDMENT FILED Type: IUAF
  • 10/26/2022 - 2 years ago
    24 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/17/2022 - 2 years ago
    23 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/26/2022 - 2 years ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/17/2022 - 2 years ago
    21 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/17/2022 - 2 years ago
    20 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/4/2022 - 2 years ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2022 - 2 years ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/2/2022 - 2 years ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/2/2022 - 2 years ago
    16 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/2/2021 - 3 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/7/2021 - 3 years ago
    14 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 9/7/2021 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/7/2021 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/25/2021 - 3 years ago
    11 - ASSIGNED TO PETITION STAFF Type: APET
  • 8/18/2021 - 3 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/15/2021 - 3 years ago
    9 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 8/2/2021 - 3 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/28/2021 - 3 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/28/2021 - 3 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/28/2021 - 3 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/28/2021 - 3 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/20/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/11/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/14/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP